Illness	Number of cases
Lymphoid leukaemia - Acute lymphoblastic leukemia not having achieved remission (C91.00)	59
Malignant neoplasm of kidney except renal pelvis (C64)	23
Agranulocytosis secondary to cancer chemotherapy (D70.10)	22
Malignant neoplasm of peripheral nerves and autonomic nervous system - Malignant neoplasm of peripheral nerves of abdomen (C47.4)	15
Agranulocytosis secondary to cancer chemotherapy (D70.13)	13
Malignant neoplasm of bone and articular cartilage of limbs (C40.0)	11
Malignant neoplasm of bone and articular cartilage of limbs (C40.2)	11
Malignant neoplasm of bone and articular cartilage of other and unspecified sites - Malignant neoplasm of pelvic bones sacrum and coccyx (C41.4)	11
Lymphoid leukaemia - Adult T-cell lymphoma/leukemia HTLV-1-associated not having achieved remission (C91.50)	11
Hodgkin lymphoma (C81.2)	10

Top 10 treatments

Treatment	Number
(9-984.7)	313
(9-984.b)	297
(8-01a)	185
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	174
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	170
Treatment by the targeted insertion of a needle into the brain, spinal cord or the eye with subsequent administration or removal of substances, e.g. fluid (8-151.4)	125
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.0)	102
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.f0)	98
Taking a tissue sample (biopsy) of the bone marrow without surgical incision (1-424)	75
(9-985.0)	71

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 1005

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 1

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ05
CQ02

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
78	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
22	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
16	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Project-related cooperation with colleges and universities
Doctoral supervision
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Lectureships / teaching posts at universities of applied sciences
Participation in multi-centre phase III/IV studies
Editors of scientific journals/textbooks

Training

No.	Training in other healing professions	Comment
HB12	Medical technical laboratory assistant (MTLA) (m/f)
HB01	Nurse and health care worker (m/f)
HB10	Midwife (m/f)
HB02	Health and paediatric nurse (m/f)
HB07	Surgical technical assistant (m/f)